Matthew Hawryluk's Net Worth
$163 Thousand
Who is Matthew Hawryluk?
Matthew Hawryluk does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Predictive Oncology Inc., and Gritstone bio, Inc..
SEC CIK
Matthew Hawryluk's CIK is 0001754470
Past Insider Trading and Trends
2023 was Matthew Hawryluk's most active year for acquiring shares with 5 total transactions. Matthew Hawryluk's most active month to acquire stocks was the month of January. 2024 was Matthew Hawryluk's most active year for disposing of shares, totalling 1 transactions. Matthew Hawryluk's most active month to dispose stocks was the month of April. 2023 saw Matthew Hawryluk paying a total of $0.00 for 234,251 shares, this is the most they've acquired in one year. In 2024 Matthew Hawryluk cashed out on 9,259 shares for a total of $6,928.51, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Predictive Oncology Inc. (POAI) Snapshot price: $0.9
InvestorMatthew Hawryluk owns 9,488 units of Common Stock which is worth $8,539.20. In the year 2023 Matthew Hawryluk acquired a total of 58,610 shares in Predictive Oncology Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.26% | 2.37K |
—
|
—
| 9.49K |
Apr 5
| |||
Form 4
| +35.65% | 1.88K |
—
|
—
| 7.13K |
Oct 2
| |||
Form 4
| +103.48% | 2.67K |
—
|
—
| 5.26K |
Jul 3
| |||
Form 4
| +55.08% | 18.36K |
—
|
—
| 51.69K |
Apr 3
| |||
Form 4
| +142.20% | 19.57K |
—
|
—
| 33.33K |
Jan 3
| |||
Form 4
|
∞
| 13.76K |
—
|
—
| 13.76K |
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gritstone bio, Inc. (GRTS) Snapshot price: $0.47
EVP, CHIEF BUSINESS OFFICERMatthew Hawryluk owns 313,931 units of Common Stock which is worth $147,547.57. From 2022 to 2024 Matthew Hawryluk acquired a total of 287,132 shares in Gritstone bio, Inc., Matthew also disposed a total of 9,259 shares of Gritstone bio, Inc. equalling to $6,928.51.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.25% | 9.89K |
$0.75 | -$6,928.51 | 313.93K |
May 15 - May 16
| |||
Form 4
| +13.90% | 35K |
—
|
—
| 286.88K |
Feb 1
| |||
Form 4
| +339.18% | 191.77K |
—
|
—
| 248.31K |
Feb 2
| |||
Form 4
| +68.09% | 21.61K |
—
|
—
| 53.35K |
Jan 31
| |||
Form 4
| +426.27% | 19.6K |
—
|
—
| 24.2K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||